News

Bioquell’s Dr Rolf Hansen examines how the latest isolator systems create aseptic working conditions for reducing risk and keeping gene, cell and CAR-T therapies efficient, compliant and accurate, whilst also supporting biologics manufacturing expansion and enabling more patients to be treated at the same time. Gene, cell and CAR-T therapies are the latest techniques that […]

Modular, lightweight and easy-to-use unit set to reduce vehicle deep clean times by more than 50% and provide safe, pathogen-free environment Bioquell (www.bioquell.com) – one of the leading global experts in reducing the risk of bio-contamination in the healthcare, life science and pharmaceutical markets – has donated an automated BQ-50 decontamination system to BUMBLEance – […]

BIOQUELL UK LTD TO HIGHLIGHT SUITABILITY OF ‘WORLD FIRST’ QUBE ASEPTIC WORK STATION FOR CAR-T, GENE AND CELL THERAPY The only isolator to offer built in Bioquell Hydrogen Peroxide Vapour technology for rapid decontamination, reduced risk and major cost benefits Bioquell UK Ltd – one of the leading global experts in reducing the risk of […]

BIOQUELL SHORTLISTED FOR UK STOCK MARKET AWARD   Bioquell UK Ltd (www.bioquell.com; tel: +44 (0) 1264 835835) – one of the leading global experts in reducing the risk of bio-contamination in the life science, healthcare and pharmaceutical markets – has been shortlisted in the highly competitive Best Health Care & Pharmaceutical PLC category of the […]

Bioquell was approached by a multinational bio-pharmaceutical company to provide remediation planning in case of a breach of sterility or contamination event across their 4 European sites. A Bioquell specialist visited each production site in turn in order to establish an emergency Hydrogen Peroxide Vapor decontamination protocol to be implemented in the event of a contamination incident. Working […]

The Polish subsidiary of a major international generics and specialty pharmaceutical manufacturer has chosen a Bioquell Qube M-11 system to provide the ideal environment for carrying out its product sterility testing. Previously, the quality department had been performing sterility testing utilising a laminar flow system and cleanroom for product protection.  The critical nature of such testing and the […]

Candida auris is an emerging pathogen with a high level of resistance to standard anti-fungal treatments. It is a causative agent of candidiasis, which when systemic (i.e. within the bloodstream) can result in high levels of mortality. The US CDC released guidance last year on the reporting, diagnosis, treatment and control of C.auris. On the 16th February, […]

Leading Biodecontamination experts Bioquell warmly welcomes the latest publication by the HSE highlighting the timescale for hydrogen peroxide-based biocides to be compliant. The HSE Biocides e-Bulletin 22 September 2016 is entitled ‘Active Substance Approval Reminder’ and summarises all of the key dates for the evaluation of hydrogen peroxide in Product Types 1, 2, 3, 4, […]

A multi-national vaccine manufacturer approached Bioquell in order to perform a Biodecontamination within its FDA approved facility. The facility itself, some 5,500 cubic meters, was treated as a single Biodecontamination enclosure with the entire process completed within 30 hours. After a successful deployment of the project,the customer contacted Bioquell wishing to establish an industry leading […]

The latest generation isolator was installed at the National Institute for Bioprocessing Research and Training (NIBRT) based in Dublin, Ireland, this February. The Bioquell QUBE, a flexible aseptic workstation, is now up and running to assist with continual professional development at this leading institute for the life sciences industry. From order to installation, it only […]